Phase 2 Clinical Trial of Attenuated<i>Salmonella enterica</i>Serovar Typhi Oral Live Vector Vaccine CVD 908-<i>htrA</i>in U.S. VolunteersCarol O. Tacket, Myron M. Levine, Karen L. Kotloff et al.|Infection and Immunity|2000Cited by 181
Safety and Immune Responses to Attenuated Salmonella enterica Serovar Typhi Oral Live Vector Vaccines Expressing Tetanus Toxin Fragment CCarol O. Tacket, Myron M. Levine, James E. Galen et al.|Clinical Immunology|2000Cited by 75